We studied a 26-year-old Portuguese patient with recessively transmitted hereditary hemolytic anemia. Protein 4.2 was absent from red cell ghosts by Western blotting. Although the 4.2 mRNA was not detected in Northern blots, it was shown to be present by a procedure based on nested reverse transcription-polymerase chain reaction (RT-PCR). Partial nucleotide sequencing disclosed a one-nucleotide deletion at nt 264 ( The phenotype was dominated by a reduction in or the absence of protein 4.2, which can easily be confused with the preceding picture. Finally, band 3 d e f i~i e n c y~~'~~ and, quite often, ankyrin deficiency2' are accompanied by a moderate reduction of protein 4.2. In such cases, however, the band 3 or ankyrin primary deficiencies are easily recognized.
which abolishes an EcoNl site, was also found in the gene of the proband (homozygous state), her parents, and her brother (heterozygous state). Apart from anemia, the patient was free of clinical manifestations. Platelet membranes were also investigated using Western blots. Antibodies to red cell protein 4.2 showed a doublet (72 and 70 kD) both in the controls and the patient. This finding raises an interesting question concerning the relationship between this doublet and erythroid protein 4. The phenotype was dominated by a reduction in or the absence of protein 4.2, which can easily be confused with the preceding picture. Finally, band 3 d e f i~i e n c y~~'~~ and, quite often, ankyrin deficiency2' are accompanied by a moderate reduction of protein 4.2. In such cases, however, the band 3 or ankyrin primary deficiencies are easily recognized.
We report a case of hereditary hemolytic anemia associated with a total protein 4.2 deficiency in =CS. It was due to a single base deletion in the protein 4.2 gene. As protein 4.2 and like proteins are known to occur in a number of tissues," we investigated the presence of protein 4.2 in platelet membranes. A protein doublet was found in both controls and in the patient using antibodies against RBC protein 4.2.
MATERIALS AND METHODS
Case report. The proband was born in 1967, 80 km north of Lisboa (Portugal). She had no major medical history until the age of 20. Several tests in 1986 failed to show any conspicuous anemia [hemoglobin (Hb) level: 124, 128, and 135 gL], suggesting retrospectively that hemolysis was compensated. In 1987, however, the patient was admitted to the hospital with anemia (RBC count: 3.19 T/L; Hb: 102 g&; hematocrit (Ht) level: 30%; reticulocyte count: 7.5%), mild icterus (bilirubin level: 2.6 mg/dL), and splenomegaly. There was no obvious reason for these acute symptoms. The leukocyte and platelet counts were normal. In 1989, she was readmitted with more severe symptoms: fever (39"C), abdominal pain, pallor, and icterus, again without any conspicuous cause (RBC count: 
I20 C L ) .
Her spleen was felt 4 cm below the costal margin. Osmotic resistance was reduced. yet moderately: 50% hemolysis for 0.049 g/L NaCl versus 0 . 0 4 0 to 0.046 g/L in controls. Incubated osmotic tests yielded more disturbed results: 50% hemolysis for 0.076 glL NaCI. vs. 0.048-0.059 g/L in controls. The blood film showed only a few spherocytes. The leukocyte count (3.0 to 5.4 G/L) and the platelet count ( I 50-178 G/L) was normal. The patient was transfused, but recovery was only partial (Hb level: 90 to I 10 g/L; RBC count: 2.9 to 3.5 T/L; elevated reticulocytes). During the period from 1988 to 1989, routine hemostasis tests (bleeding time, prothrombin level, partial thromboplastin time) were always normal.
Splenectomy was performed in August 1990 and was followed by a remarkable improvement [RBC count: 4.35 T/L; Hb level: 126 glL; Ht level: 38%: reticulocyte count: 3.2% (values from 1991 and 1992)l. Blood smears showed a few spherocytes (Fig I) . Osmotic resistance remained slightly altered (50% hemolysis for 0.047 g/L NaCI); the pink test"' was considered to be normal (12.5% versus 7.4% and 6.5% for the controls). In March 1994. hemostasis tests (see above) were normal, as was platelet aggregation tested using adenosine triphosphate (ADP 5 and 10 pmol/L), collagen (5.0 and 10.0 pglmL), or arachidonic acid ( I 1 .0 mmol/L).
The father, the mother, and a brother (born in 1939, 1945, and 1979, respectively) are apparently healthy. The father and the mother are not aware of being related, but they originate from the same area.
RBC membrane proteins. Total membrane proteins were studied using sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), according to the method of Laemmli" or Fairbanks et al."" After Coomassie blue staining, gels were scanned by densitometry using a Cellosystem (Sebia. Paris, France). Western blots were performed using the biotin-streptavidin procedure for high sensitivity revelation (Amersham-France. Les Ulis. France). We used rabbit anti-protein 4.2 polyclonal antibodies prepared in Lyon, France.
Reticulocyte. protein 4.2 mRNA. Total reticulocyte mRNA from the proposita was extracted from peripheral blood as previously reported."' Northern blot analysis was performed"'using a full-length protein 4.2 cDNA probe provided by C. Korsgren and C.M. Cohen (St Elizabeth's Hospital. Boston, MA). ' We used a cDNA m-globin probe" as an internal standard. Reverse transcription (RT) and polymerase chain reaction (PCR) were performed as reported."' Briefly, a first PCR amplification was accomplished using primers A and B (Table I and Fig 2; 92°C for 60 seconds, 64°C for 30 seconds, 72°C for 60 seconds). Formamide (3%) was present in the reaction mixture. A second (nested) PCR amplification was performed on 'AII of the intermediary product with either primers C and D (92°C for 60 seconds, 64°C for 30 seconds, 72°C for 60 seconds: 3% formamide) or primers E and F (92°C for 60 seconds, 60°C for 30 seconds, 72°C for 60 seconds). The final products were cloned as EcoRI inserts into a PUClX EcoRIIBAP vector (Pharmacia LKB, Uppsala, Sweden). Nucleotide sequencing was performed with the Sequenase kit (United States Biochemical Corp. Cleveland, OH) using universal MI3/PUC primers and primers A to F (Table I) .
Protein 4.2 gene. Genomic DNA was obtained from leukocytes" and PCR-amplified as follows: ( I ) 92°C for 60 seconds, 56°C for 60 seconds, 72°C for 60 seconds using primers C and G (analysis of part of exon 2); (2) 92°C for 60 seconds, 52°C for 60 seconds, 72°C for 60 seconds using primers H and I (analysis of the putative promoter region): or (3) 92°C for 60 seconds, 60°C for 30 seconds, 72°C for 60 seconds using primers J and K (analysis of exon I). For the proposita, single-stranded DNA was obtained by asymmetric PCR" using a 100-fold excess of primer G, H, or K with regard to primer C, 1, or J, respectively. Primer C, I, J, A, or E was used as primer for direct nucleotide sequencing. To screen the one-base deletion, one tenth of the amplified fragments (extending from primers C and G) were purified and digested with the restriction endonuclease EcoNI according to the manufacturer's specifications (New England Biolabs, Beverly, MA). Digestion was performed in a control, the father, the mother, the proposita. and the brother.
Plarclcr proteins. Human platelets were prepared at room temperature according to the method of Friedrichs et al" with some modifications. Blood (50 mL) was drawn in a solution containing 0.17 mol/L sodium citrate buffer (ACD), pH 4.5, and 50 ng/mL prostacyclin. Erythrocytes were pelleted (160g, 20 minutes). Two volumes of the supernatant (platelet-rich plasma) were added to one 
RESULTS
RBC proteins. SDS-PAGE showed the absence of protein 4.2 in the proband (Fig 3) . The amount of spectrin (a and 0 chains) was expressed with respect to band 3. The (a Fig 3) . In the father, mother, and brother of the propositus, the amounts of protein 4.2 (with respect to band 3) were normal: 12.2%, 12.6%, and 12.6%, respectively, versus 13.0% 2 0.8% in six controls.
Protein 4.2 mRNA. In the propositus, Northern blots did not show protein 4.2 mRNA in the reticulocytes (Fig 4) . Hybridization with an a-globin probe indicated that this was not due to artifactual degradation of RNA during preparation.
The nucleotide sequence of the protein 4.2 cDNA was determined from position -9 to 1017 in the propositus. Because of the very low amounts of protein 4.2 mRNA, amplified cDNA was obtained using nested PCR. We found a onenucleotide deletion at nt 264 (or 265): AAG GTG + AAG TG, ie, in codon 88 (or 89) that belongs to exon 2 (Fig 5) . This change placed in frame the nonsense triplet that normally overlaps codons 136 and 137 ( G m C C ) . Furthermore, cloning and sequencing the DNA from nested PCR showed spliceoforms not previously described (Fig 6) . A different pattern of spliceoforms was observed in the controls and in the proband. The major spliceoforms in the controls
RBC membrane protein analysis and Western blots. (Left) SDS-PAGE (5%-15% gradient acrylamide gel, according t o Laemmli"): C, control; F, father; M, mother; P, propositus. The brother's profile was normal (not shown). The reduction of band 6 (glyceraldehyde 3-phosphate dehydrogenase) given by the propositus was due t o the fact that we used membranes recovered after high salt treatment in this particular experiment (in view of RNA preparation). (Right) Western blots, using polyclonal antibodies t o RBC protein 4.2 and the biotin-streptavidin procedure: C, control. P', the propositus (member IV.21 for allele 4. 2 Fig 6 ) were only minor forms in the proband, in agreement with the Northern blot results. Among the spliceoforrns exhibited by the propositus, one (fragment of 128 nt) was detected in the controls, whereas two spliceoforrns were not (fragments of 378 and 519 nt). An additional minor spliceoform with en bloc skipping of exons 3 to 5 was seen for the propositus and not in the control (not shown in Fig 6 as it was obtained from a different experiment using primers A B and then primers CD).
Taken together, these differences bear on minor spliceoforms, and it is doubtful that they have biologic significance in the proband (see Discussion). Protein 4.2 gene. The deletion observed at nt 264 (or 265) abolished an EcoNI site (CCTNsAGG + CCTN5AG).
Amplified genomic DNA fragments (primers C and G) from the different members of the family were digested with EcoNI (Fig 7) . The normal allele generated two fragments of 1189 nt and 55 nt (the latter being not visible in Fig 7) , whereas allele Lisboa yielded a 1,244 nt fragment. The father, the mother, and the brother were heterozygous, and the propositus was homozygous for the mutation. affinity-purified antibodies to RBC protein 4.2 disclosed two minor components of 72 and 70 kD (Fig 8) . The ratio of the two bands varied from one control to another. In the proband, 
For personal use only. on August 30, 2017. by guest www.bloodjournal.org From this doublet was also present, and, in this particular case, Until further information is available, we will use the nonthe 70-kD band was more pronounced than the 72-kD band.
specific term of hereditary hemolytic anemia. In a previous study," this doublet appeared as a single band.
Although RBC protein 4.2 was not detected in the proDifferences in SDS-PAGE conditions may account for this band, no reduction of this protein was found in the parents' variation.
erythrocytes. Because of excess synthesis, the normal haploid set of protein 4.2 presumably fulfills the needs of the The one-base deletion in allele 4.2 Lisboa is sufficient to account for the hemolytic disorder because it leads to a frameshift (followed by premature termination). The almost complete absence of protein 4.2 mRNA in reticulocytes from the present patient is consistent with previous observations of abolished initiation codon or premature stop codons in other systems.3s4' Spliceoforms of erythroid protein 4.2 mRNA not previously described were observed (Fig 6 ) , and the major spliceoforms were decreased. This is consistent with the apparent absence of protein 4.2 mRNA in Northern ,1244
blots. In the control, the 519 nt fragment was possibly masked by the 548 nt fragment.
. 89 One minor spliceoform (fragment of 378 nt) and a spliceoin the proband's but not in the controls' reticulocytes. The reason for this is not clear. Interestingly, however, such spliceoforms could restore the reading frame and would yield The mode of inheritance was recessive. In the homozygous state, the clinical condition did not manifest a hemolytic state, although acute episodes had occurred before splenectomy. Splenectomy was efficient. It is not certain whether this condition should be categorized as hereditary spherocytosis stricto sensu in view of the scarcity of spherocytes and the limited decrease in the osmotic resistance. (codons 88-89 to 95). Yet, it is not sure how functional these polypeptides would be. (No species of the corresponding molecular weights were seen on Western blots.) Whether or not the spliceoforms seen in the proband's, but not in the controls', reticulocytes would be specifically triggered by the mutation as an attempt to overcome the mutation itself,j'.'' they remain minor and would probably not compensate for normal protein 4.2 in the RBCs.
The present mutation raises a number of conflicting questions in view of the following facts: ( I ) the patient had no symptoms other than those affecting RBCs, (2) proteins reacting with antibodies to RBC protein 4.2 occur in a number of tissues," (3) protein 4.2 is apparently encoded by one gene,' and (4) a one-base deletion in such a gene might not be easy to overcome. Significantly, we found a minor doublet (72 and 70 kD) when proteins from platelet membranes reacted in Western blotting with two different preparations of purified antibodies to RBC protein 4.2. The same pattern was seen in the control and in the proband. In the proband, the 70-kD band was more pronounced than the 72-kD band, which also occurred in some controls. The platelet protein in the patient might emerge from allele 4.2 Lisboa itself through splicing events that would bypass the frameshift mutation and simultaneously keep the overall molecular weights. Alternatively, the immunoreactive protein would be the product of a distinct but related gene.
In summary, we have described a case of hereditary hemolytic anemia associated with a total deficiency in RBC protein 4.2. The primary change, a single base deletion in exon 2 of protein 4.2 gene, yielded a frameshift followed by premature termination. The proband was apparently devoid of nonerythroid manifestations. Her platelets normally contained two components (72 and 70 kD) reacting with antibodies to RBC protein 4. 23. Alloisio N, Texier P, Forissier A, Ribeiro ML, MorlC L, Bozon M, Bursaux E, Maillet P, Tanner MJA, Tamagnini G, Delaunay
